4 results
Primary Objective: To determine whether topical application of Calcitriol (Silkis) 3 µg/g, Diclofenac 10% or a combination of both can lead to a 40% histological reduction (*)/increase (*) of expression of the following antibodies: Ki67 (*), BCL2…
Primary objective: To compare progression-free survival (PFS) as assessed by blinded, central review between patients randomized to niraparib versus physician*s choice. Key secondary objective: To compare overall survival between patients randomized…
The main objective is to study the efficacy of treatment with RTX in patients with relapsing PMR compared to placebo.
The main objective is to study the efficacy of treatment with RTX in patients with newly diagnosed PMR compared to placebo.